Literature DB >> 8383580

A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities.

J Kaern1, C G Tropé, V M Abeler.   

Abstract

METHODS: Three-hundred seventy patients with borderline tumors treated between 1970 and 1982 at the Norwegian Radium Hospital were analyzed retrospectively for clinicopathologic features, treatment, and survival characteristics.
RESULTS: One hundred seventy-eight patients had mucinous tumors, 174 patients had serous tumors, and 18 patients had other types of tumors. There were 311 patients with Stage I, 20 with Stage II, and 39 with Stage III tumors by the classification of the International Federation of Gynecology and Obstetrics. Most of the patients were treated in conformity with the protocols for invasive carcinoma at the current time. Total abdominal hysterectomy, bilateral adnexectomy, and omentectomy were performed in 287 patients and less extensive surgery was performed in 77 patients. Only six patients had residual tumor after surgery. The independent prognostic factors evaluated by Cox analysis in regard to corrected (dead of disease) short-term and long-term survival were stage (P < 0.0001) and histologic type (P = 0.0144); age (P = 0.0115) affected only long-term survival. Adjuvant treatment was of no benefit.
CONCLUSIONS: Stage, histologic type, and age had prognostic significance. Fertility-saving surgery can be offered to patients with Stage IA disease with serous or mucinous tumors.

Entities:  

Mesh:

Year:  1993        PMID: 8383580     DOI: 10.1002/1097-0142(19930301)71:5<1810::aid-cncr2820710516>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  HER2-positive mucinous adenocarcinomas of the ovary have an expansile invasive pattern associated with a favorable prognosis.

Authors:  Sang Kyum Kim; Nam Hoon Cho
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013.

Authors:  U Wagner; P Harter; F Hilpert; S Mahner; A Reuß; A du Bois; E Petru; W Meier; P Ortner; K König; K Lindel; D Grab; P Piso; O Ortmann; I Runnebaum; J Pfisterer; D Lüftner; N Frickhofen; F Grünwald; B O Maier; J Diebold; S Hauptmann; F Kommoss; G Emons; B Radeleff; M Gebhardt; N Arnold; G Calaminus; I Weisse; J Weis; J Sehouli; D Fink; A Burges; A Hasenburg; C Eggert
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-09       Impact factor: 2.915

3.  Management of Borderline Ovarian Tumors-Still a Gray Zone.

Authors:  Nidhi Nayyar; Prerna Lakhwani; Ashish Goel; Pankaj Kr Pande; Kapil Kumar
Journal:  Indian J Surg Oncol       Date:  2017-08-25

4.  A nationwide study of serous "borderline" ovarian tumors in Denmark 1978-2002: centralized pathology review and overall survival compared with the general population.

Authors:  Charlotte Gerd Hannibal; Russell Vang; Jette Junge; Kirsten Frederiksen; Anette Kjaerbye-Thygesen; Klaus Kaae Andersen; Ann Tabor; Robert J Kurman; Susanne K Kjaer
Journal:  Gynecol Oncol       Date:  2014-06-10       Impact factor: 5.482

Review 5.  Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.

Authors:  Murray Joseph Casey; Chhanda Bewtra
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

6.  A meta-analysis on the impact of platinum-based adjuvant treatment on the outcome of borderline ovarian tumors with invasive implants.

Authors:  Ines Vasconcelos; Jessica Olschewski; Ioana Braicu; Jalid Sehouli
Journal:  Oncologist       Date:  2015-01-19

Review 7.  Management, prognosis and reproductive outcomes of borderline ovarian tumor relapse during pregnancy: from diagnosis to potential treatment options.

Authors:  Francesco Cosentino; Luigi Carlo Turco; Stefano Cianci; Francesco Fanfani; Anna Fagotti; Salvatore Gueli Alletti; Giuseppe Vizzielli; Salvatore Giovanni Vitale; Antonio Simone Laganà; Francesco Padula; Claudio Coco; Salvatore Pisconti; Giovanni Scambia
Journal:  J Prenat Med       Date:  2016 Jan-Jun

Review 8.  [Mucinous ovarian neoplasms. Prognostically mostly excellent, infrequently a wolf in sheep's clothing].

Authors:  S Lax; A Staebler
Journal:  Pathologe       Date:  2014-07       Impact factor: 1.011

9.  Association of pancreatic adenocarcinoma up-regulated factor expression in ovarian mucinous adenocarcinoma with poor prognosis.

Authors:  Sang Kyum Kim; Si Young Song; Sunghoon Kim; Nam Hoon Cho; Ga Won Yim; Sang Wun Kim; Young Tae Kim; Eun Ji Nam
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

Review 10.  Low-Grade Serous Ovarian Cancer: Current Treatment Paradigms and Future Directions.

Authors:  Rachel N Grisham; Gopa Iyer
Journal:  Curr Treat Options Oncol       Date:  2018-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.